News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
103,569 Results
Type
Article (3089)
Company Profile (12)
Press Release (100468)
Multimedia
Podcasts (5)
Webinars (2)
Section
Business (36459)
Career Advice (67)
Deals (6133)
Drug Delivery (13)
Drug Development (11935)
Employer Resources (13)
FDA (1958)
Job Trends (2379)
News (54157)
Policy (3035)
Tag
Academia (242)
Accelerated approval (14)
Allergies (42)
Alliances (3644)
ALS (62)
Alzheimer's disease (294)
Antibody-drug conjugate (ADC) (143)
Approvals (2207)
Artificial intelligence (223)
Autoimmune disease (85)
Automation (20)
Bankruptcy (56)
Best Places to Work (2395)
BIOSECURE Act (3)
Biosimilars (69)
Biotechnology (11)
Bladder cancer (109)
Brain cancer (14)
Breast cancer (305)
Cancer (2075)
Cardiovascular disease (174)
Career advice (67)
Career pathing (4)
CAR-T (90)
CDC (6)
Cell therapy (243)
Cervical cancer (22)
Clinical research (12712)
Collaboration (735)
Company closure (1)
Compensation (762)
Complete response letters (10)
COVID-19 (322)
CRISPR (35)
C-suite (308)
Cystic fibrosis (48)
Data (2726)
Decentralized trials (1)
Depression (36)
Dermatology (25)
Diabetes (148)
Diagnostics (1160)
Digital health (14)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (105)
Drug pricing (20)
Drug shortages (4)
Duchenne muscular dystrophy (81)
Earnings (33557)
Editorial (4)
Employer branding (1)
Employer resources (10)
Events (13681)
Executive appointments (409)
FDA (3333)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (1)
Frontotemporal dementia (17)
Funding (584)
Gene editing (71)
Generative AI (11)
Gene therapy (186)
GLP-1 (248)
Government (408)
Grass and pollen (3)
Guidances (319)
Healthcare (2951)
HIV (39)
Huntington's disease (15)
IgA nephropathy (47)
Immunology and inflammation (53)
Immuno-oncology (25)
Indications (63)
Infectious disease (432)
Inflammatory bowel disease (47)
Inflation Reduction Act (2)
Influenza (38)
Intellectual property (64)
Interviews (7)
IPO (4725)
IRA (3)
Job creations (259)
Job search strategy (55)
JPM (2)
Kidney cancer (8)
Labor market (16)
Layoffs (45)
Leadership (3)
Legal (528)
Liver cancer (30)
Longevity (5)
Lung cancer (314)
Lymphoma (171)
Machine learning (20)
Management (5)
Manufacturing (248)
MASH (60)
Medical device (2433)
Medtech (2463)
Mergers & acquisitions (1824)
Metabolic disorders (396)
mRNA (12)
Multiple sclerosis (50)
NASH (5)
Neurodegenerative disease (124)
Neuropsychiatric disorders (35)
Neuroscience (726)
NextGen: Class of 2026 (744)
Non-profit (554)
Now hiring (3)
Obesity (189)
Opinion (10)
Ovarian cancer (69)
Pain (48)
Pancreatic cancer (65)
Parkinson's disease (97)
Patents (108)
Patient recruitment (203)
Peanut (18)
People (4278)
Pharmaceutical (5)
Pharmacy benefit managers (6)
Phase 1 (3361)
Phase 2 (5241)
Phase 3 (5008)
Pipeline (3451)
Policy (17)
Postmarket research (438)
Preclinical (1015)
Press Release (2)
Prostate cancer (117)
Psychedelics (13)
Radiopharmaceuticals (48)
Rare diseases (289)
Real estate (365)
Recruiting (2)
Regulatory (3365)
Reports (18)
Research institute (233)
Resumes & cover letters (4)
Rett syndrome (25)
RNA editing (1)
RSV (42)
Schizophrenia (53)
Series A (82)
Series B (77)
Sickle cell disease (29)
Special edition (4)
Spinal muscular atrophy (16)
Sponsored (4)
Startups (213)
Stomach cancer (1)
Supply chain (38)
Tariffs (5)
The Weekly (5)
Vaccines (181)
Venture capital (21)
Weight loss (98)
Women's health (40)
Worklife (3)
Date
Today (46)
Last 7 days (163)
Last 30 days (1015)
Last 365 days (11746)
2026 (3128)
2025 (12049)
2024 (8881)
2023 (7228)
2022 (8670)
2021 (8987)
2020 (8239)
2019 (6997)
2018 (5162)
2017 (4301)
2016 (3450)
2015 (4307)
2014 (2820)
2013 (1766)
2012 (2103)
2011 (2551)
2010 (2402)
Location
Africa (69)
Alabama (16)
Arizona (42)
Arkansas (5)
Asia (5562)
Australia (803)
California (5287)
Canada (1083)
China (339)
Colorado (200)
Connecticut (230)
Delaware (226)
Europe (14674)
Florida (488)
Georgia (130)
Hawaii (3)
Idaho (9)
Illinois (392)
India (20)
Indiana (145)
Iowa (7)
Japan (272)
Kansas (16)
Kentucky (19)
Louisiana (20)
Maine (15)
Maryland (449)
Massachusetts (3847)
Michigan (132)
Minnesota (247)
Mississippi (1)
Missouri (55)
Montana (4)
Nebraska (3)
Nevada (60)
New Hampshire (28)
New Jersey (1311)
New Mexico (7)
New York (1134)
North Carolina (493)
North Dakota (2)
Northern California (2619)
Ohio (134)
Oklahoma (6)
Oregon (6)
Pennsylvania (705)
Puerto Rico (4)
Rhode Island (15)
South America (112)
South Carolina (6)
Southern California (2066)
Tennessee (78)
Texas (749)
United States (16806)
Utah (95)
Vermont (1)
Virginia (117)
Washington D.C. (18)
Washington State (358)
West Virginia (3)
Wisconsin (92)
103,569 Results for "36".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Clinical research
Pharma R&D Spend Drops 3.6% as Pipeline Prioritizations Take Shape
Overall, the top 16 largest pharmaceutical companies spent $159 billion on research and development in 2025, compared to $165 billion the year prior. Here’s where all that cash went at companies like Johnson & Johnson, Amgen and Pfizer.
March 25, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
March 12, 2026
·
4 min read
Press Releases
EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference
March 10, 2026
·
1 min read
Press Releases
Koya Medical to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
March 12, 2026
·
1 min read
Press Releases
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year
April 6, 2026
·
2 min read
Press Releases
Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
March 5, 2026
·
1 min read
Press Releases
MannKind to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 19, 2026
·
1 min read
Press Releases
Sitryx to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 19, 2026
·
1 min read
Press Releases
Innoviva to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 19, 2026
·
2 min read
Press Releases
Immuneering to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 18, 2026
·
1 min read
1 of 10,357
Next
